ACXP Acurx Pharmaceuticals, Inc. - Common Stock
$1.59
Price · Aug 18, 2026
Fundamentals as of Aug 13, 2026
52W Range
$1–$8
4% of range
Analyst Rating
BUY
9 analysts
Price Target
$17
+969% upside
P/E (TTM)
-0.4
ROE
-180.3%
Net Profit Margin
—
ACXP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.59
Market Cap
$5M
P/E (TTM)
-0.4
EPS (TTM)
$-5.32
Revenue (TTM)
—
Div Yield
—
ROE
-180.3%
Debt/Equity
—
52W Range
$1 – $8
ACXP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-5.32
2020-12-31
→
2025-12-31
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ACXP
Peer Median
P/E (TTM)
-0.4
—
P/B
1.0
1.2
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ACXP
Peer Median
ROA
-138.0%
-130.8%
ROE
-180.3%
-192.5%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ACXP
Peer Median
Quick Ratio
3.1
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ACXP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ACXP
Peer Median
ACXP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 2 22.2%
- Buy 6 66.7%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-08-14
Median
$10.00
Mean
$17.00
← Below all targets
$1.59
Low
$10.00
High
$31.00
Median target
$10.00
+528.9%
Mean target
$17.00
+969.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.42%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.62 | $-0.65 | 0.03% |
| Dec. 31, 2025 | $-0.31 | $-1.01 | 0.70% |
| Sept. 30, 2025 | $-1.23 | $-1.34 | 0.11% |
| June 30, 2025 | $-1.89 | $-2.31 | 0.42% |
| March 31, 2025 | $-2.20 | $-3.06 | 0.86% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| FBLG | — | -0.5 | — | — | — | — |
| ERNA | — | — | — | — | — | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | — |
| CDIO | — | — | — | — | — | — |
| PMCB | $8M | -0.3 | — | — | -56.7% | — |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| XBIO | — | -1.4 | 19.0% | — | — | — |
| DRMA | — | — | — | — | — | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $5M | $6M | $5M | $2M | $2M | |
| SG&A Expense | $6M | $9M | $9M | $7M | $11M | · | |
| Operating Expenses | $8M | $14M | $15M | $12M | $13M | $5M | |
| Operating Income | $-8M | $-14M | · | · | · | · | |
| Interest Income | $125.4K | $20.1K | · | · | · | · | |
| Income Tax | · | · | · | $0 | · | $0 | |
| Net Income | $-8M | $-14M | $-15M | $-12M | $-13M | $-5M | |
| EPS (Basic) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 | |
| EPS (Diluted) | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 | $-0.74 | |
| Shares (Basic) | 1,498,793 | 808,168 | 12,671,572 | 10,816,412 | 8,535,873 | 6,190,875 | |
| Shares (Diluted) | 1,498,793 | 808,168 | 12,671,572 | 10,816,412 | 8,535,873 | 6,190,875 | |
| EBITDA | $-8M | · | · | · | · | · |
Balance Sheet 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $4M | $7M | $9M | $13M | $3M | |
| Prepaid Expense | $85.0K | $100.1K | $105.8K | $265.0K | $295.3K | $48.6K | |
| Current Assets | · | $4M | $8M | $9M | $13M | · | |
| Total Assets | $8M | $4M | $8M | $9M | $13M | $3M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $843.9K | $455.9K | |
| Current Liabilities | $2M | $3M | $3M | $2M | $843.9K | $472.6K | |
| Total Liabilities | $2M | $3M | $3M | $2M | $843.9K | $522.4K | |
| Common Stock | $2.3K | $852 | $14.5K | $11.6K | $10.2K | · | |
| Paid-in Capital | $81M | $68M | $58M | $46M | $39M | · | |
| Retained Earnings | $-75M | $-67M | $-53M | $-39M | $-27M | $-14M | |
| Stockholders' Equity | $5M | $615.1K | $5M | $7M | $12M | $3M | |
| Liabilities + Equity | $8M | $4M | $8M | $9M | $13M | $3M | |
| Shares Outstanding | 2,348,113 | 851,534 | 723,411 | 11,627,609 | 10,215,792 | 0 |
Cash Flow 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $3M | $3M | $3M | $5M | $695.8K | |
| Operating Cash Flow | $-7M | $-10M | $-10M | $-8M | $-5M | $-3M | |
| Stock Issued | · | · | · | $4M | · | · | |
| Net Stock Activity | · | · | · | $4M | · | · | |
| Financing Cash Flow | $11M | $7M | $8M | $4M | $15M | $4M | |
| Net Change in Cash | $4M | $-4M | $-2M | $-4M | $10M | $692.1K |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -138.0% | -243.8% | -170.6% | -106.9% | -154.7% | · | |
| ROE | -180.3% | -860.2% | -339.0% | -141.6% | · | · |
Liquidity & Solvency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Quick Ratio | 3.1 | 1.1 | 2.5 | 4.4 | 15.4 | · |
Valuation (TTM) 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | $-14M | $-15M | $-12M | $-13M | · | |
| Market Cap | $6M | $277M | $1.11B | $926M | $883M | · | |
| P/E | -0.5 | -0.9 | -66.6 | -71.1 | -58.0 | · | |
| P/B | 1.1 | 450.7 | 237.5 | 126.5 | · | · | |
| P / Tangible Book | 1.1 | 450.7 | 237.5 | 126.5 | 71.1 | · | |
| P / Cash Flow | -0.9 | -26.7 | -113.1 | -122.7 | -176.1 | · | |
| Earnings Yield | -213.6% | -107.2% | -1.5% | -1.4% | -1.7% | · |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $1M | $341.5K | $281.8K | $429.7K | $524.2K | $598.8K | $825.1K | $1M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $2M | |
| SG&A Expense | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | · | · | · | · | · | · | · | |
| Interest Income | $53.1K | $35.0K | $38.8K | $35.9K | $23.4K | $27.3K | $12.0K | $5.0K | $782 | · | · | · | · | · | · | · | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | $-5M | $-3M | $-3M | $-3M | $-3M | $-4M | |
| EPS (Basic) | $-0.53 | $-0.62 | $-2.09 | $-1.23 | $-1.89 | $-2.15 | $-8.51 | $-3.45 | $-5.21 | $-0.28 | $-0.38 | $-0.24 | $-0.28 | $-0.25 | $-0.28 | $-0.32 | |
| EPS (Diluted) | $-0.53 | $-0.62 | $-2.09 | $-1.23 | $-1.89 | $-2.15 | $-8.51 | $-3.45 | $-5.21 | $-0.28 | $-0.38 | $-0.24 | $-0.28 | $-0.25 | $-0.28 | $-0.32 | |
| Shares (Basic) | 4,259,540 | 2,718,433 | -21,355,926 | 1,625,805 | 1,190,266 | 1,001,932 | -16,273,746 | 818,174 | 791,233 | 15,472,507 | -24,159,432 | 13,005,128 | 12,186,481 | 11,639,395 | -20,828,035 | 11,148,402 | |
| Shares (Diluted) | 4,259,540 | 2,718,433 | -21,355,926 | 1,625,805 | 1,190,266 | 1,001,932 | -16,273,746 | 818,174 | 791,233 | 15,472,507 | -24,159,432 | 13,005,128 | 12,186,481 | 11,639,395 | -20,828,035 | 11,148,402 | |
| EBITDA | $-2M | $-2M | · | $-2M | $-2M | · | · | · | · | · | · | · | · | · | · | · |
Balance Sheet 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $9M | $8M | $6M | $6M | $5M | $4M | $6M | $6M | $9M | $7M | $7M | $9M | $7M | $9M | $11M | |
| Prepaid Expense | $233.1K | $228.8K | $85.0K | $158.2K | $53.5K | $161.6K | $100.1K | $122.8K | $168.4K | $187.9K | $105.8K | $105.7K | $89.9K | $206.6K | $265.0K | $337.8K | |
| Current Assets | · | · | · | · | $6M | $5M | · | $6M | · | · | · | $7M | $9M | $7M | · | $11M | |
| Total Assets | $11M | $10M | $8M | $6M | · | · | $4M | · | $7M | $9M | $8M | · | · | · | $9M | · | |
| Accounts Payable | $3M | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Current Liabilities | $3M | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Total Liabilities | $3M | $3M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Common Stock | $4.7K | $3.4K | $2.3K | $1.8K | $1.5K | $22.4K | $852 | $16.8K | $16.0K | $15.8K | $14.5K | $13.0K | $13.0K | $11.7K | $11.6K | $11.6K | |
| Paid-in Capital | $87M | $84M | $81M | $77M | $75M | $72M | $68M | $67M | $65M | $64M | $58M | $52M | $51M | $47M | $46M | $45M | |
| Retained Earnings | $-79M | $-77M | $-75M | $-74M | $-72M | $-69M | $-67M | $-65M | $-62M | $-58M | $-53M | $-48M | $-45M | $-42M | $-39M | $-35M | |
| Stockholders' Equity | $8M | $7M | $5M | $4M | $4M | $2M | $615.1K | $3M | $3M | $6M | $5M | $4M | $6M | $5M | $7M | $10M | |
| Liabilities + Equity | $11M | $10M | $8M | $6M | $6M | $5M | $4M | $6M | $7M | $9M | $8M | $7M | $9M | $7M | $9M | $11M | |
| Shares Outstanding | 4,683,253 | 3,389,106 | 2,348,113 | 1,800,299 | 1,470,352 | 22,397,511 | 851,534 | 16,770,378 | 15,996,168 | 15,757,102 | 14,468,229 | 13,005,128 | 13,005,128 | 11,671,795 | 11,627,609 | 11,592,609 |
Cash Flow 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $200.5K | $258.3K | $294.8K | $294.8K | $324.2K | $333.6K | $345.2K | $345.2K | $1M | $894.5K | $833.3K | $833.3K | $806.5K | $733.5K | $697.0K | $697.0K | |
| Operating Cash Flow | $-2M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-2M | $-2M | $-2M | $-1M | $-2M | |
| Financing Cash Flow | $3M | $3M | $3M | $2M | $3M | $3M | $194.5K | $2M | $320.2K | $5M | $5M | $0 | · | · | $-1 | · | |
| Net Change in Cash | $1M | $2M | $2M | $-157.3K | $1M | $937.2K | $-2M | $-598.3K | $-3M | $1M | $421.9K | $-2M | $2M | $-2M | $-1M | $2M |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -25.7% | -18.0% | · | -18.9% | · | · | · | · | -52.0% | -42.9% | · | · | · | · | · | · | |
| ROE | -38.5% | -36.1% | · | -63.2% | -64.2% | -51.7% | · | -85.5% | -85.5% | -77.4% | · | -45.5% | -110.8% | -109.3% | · | -72.5% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 2.4 | 1.9 | · | 1.8 | · | · | · | 2.2 | 3.1 | 3.6 | · | 9.3 | |
| Quick Ratio | 3.8 | 3.7 | · | 2.4 | 2.3 | 1.9 | · | 1.7 | 2.0 | 2.9 | · | 2.2 | 3.0 | 3.5 | · | 9.0 |
Valuation (TTM) 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | $-8M | · | $-9M | $-11M | $-13M | · | $-14M | $-15M | $-14M | · | $-13M | $-13M | $-12M | · | $-13M | |
| Market Cap | $7M | $13M | · | $8M | $15M | $175M | · | $637M | $720M | $772M | · | $390M | $689M | $808M | · | $696M | |
| P/E | -0.4 | -0.6 | · | -0.6 | -1.0 | -0.9 | · | -4.1 | -7.5 | -46.7 | · | -27.5 | -47.7 | -63.5 | · | -46.2 | |
| P/B | 0.9 | 1.8 | · | 2.1 | 4.2 | 75.6 | · | 239.2 | 210.0 | 128.7 | · | 99.2 | 110.9 | 152.1 | · | 71.2 | |
| P / Tangible Book | 0.9 | 1.8 | · | 2.1 | 4.2 | 75.6 | · | 239.2 | 210.0 | 128.7 | · | 99.2 | 110.9 | 152.1 | · | 71.2 | |
| P / Cash Flow | · | -8.9 | · | · | · | -85.2 | · | · | · | -252.1 | · | · | · | -417.9 | · | · | |
| Earnings Yield | -275.5% | -158.8% | · | -155.7% | -104.3% | -116.0% | · | -24.2% | -13.4% | -2.1% | · | -3.6% | -2.1% | -1.6% | · | -2.2% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-8M | $-14M | $-15M | $-12M | $-13M |
| Diluted EPS | $-5.32 | $-17.45 | $-1.15 | $-1.12 | $-1.49 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Quick Ratio | 3.1 | 1.1 | 2.5 | 4.4 | 15.4 |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 21 filers · $229K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (-1 vs prior Q) | 4 (+1 vs prior Q) | 3 (0 vs prior Q) | 4 (0 vs prior Q) | +23K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $48,203 | 31,099 | 21.02% | Shares |
| VANGUARD GROUP INC | $40,350 | 16,205 | 17.59% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $39,289 | 25,347 | 17.13% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $25,118 | 16,205 | 10.95% | Shares |
| JANE STREET GROUP, LLC | $21,559 | 13,909 | 9.40% | Shares |
| Prospect Financial Services LLC | $21,367 | 13,785 | 9.32% | Shares |
| MORGAN STANLEY | $11,625 | 7,500 | 5.07% | Shares |
| Integrated Wealth Concepts LLC | $7,330 | 4,729 | 3.20% | Shares |
| Tower Research Capital LLC (TRC) | $4,253 | 2,744 | 1.85% | Shares |
| WELLS FARGO & COMPANY/MN | $3,565 | 2,300 | 1.55% | Shares |
| Westside Investment Management, Inc. | $2,558 | 1,650 | 1.12% | Shares |
| LANARK FINANCIAL, INC. | $2,325 | 1,500 | 1.01% | Shares |
| Semmax Financial Advisors Inc. | $684 | 153 | 0.30% | Shares |
| BARCLAYS PLC | $436 | 281 | 0.19% | Shares |
| Cornerstone Planning Group LLC | $245 | 167 | 0.11% | Shares |
| OSAIC HOLDINGS, INC. | $155 | 100 | 0.07% | Shares |
| GROUP ONE TRADING LLC | $147 | 95 | 0.06% | Shares |
| BlackRock, Inc. | $93 | 60 | 0.04% | Shares |
| Caitong International Asset Management Co., Ltd | $36 | 23 | 0.02% | Shares |
| SBI Securities Co., Ltd. | $9 | 6 | 0.00% | Shares |
| UBS Group AG | $5 | 3 | 0.00% | Shares |
Company insiders 8 insiders · 2 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| David P Luci | President and CEO | April 20, 2026 A | 1,097,458 | 0 | 0 | $0 |
| Robert G. Shawah | Chief Financial Officer | April 20, 2026 A | — | 0 | 0 | $0 |
| James J. Donohue | Director | April 20, 2026 A | 22,352 | 0 | 0 | $0 |
| Carl Sailer | Director | April 20, 2026 A | 137,183 | 0 | 0 | $0 |
| Jack H Dean | Director | April 20, 2026 A | 21,776 | 0 | 0 | $0 |
| Joseph C Scodari | Director | April 20, 2026 A | 27,708 | 0 | 0 | $0 |
| Thomas L Harrison | Director | April 20, 2026 A | — | 0 | 0 | $0 |
| DELUCCIA ROBERT J | Director | April 20, 2026 A | 1,010,196 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Robert J. DeLuccia | July 6, 2021 | — | Initial filing | Passive investment | SEC |
| David P. Luci | July 6, 2021 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 31,099 SH | Aug. 8, 2026 | Daily |